{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:52:20Z","timestamp":1794639140251,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92201-7","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:31:52Z","timestamp":1740828712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of a whole blood coagulometer sensitive to the direct oral anticoagulants"],"prefix":"10.1038","volume":"15","author":[{"given":"Sasha H.","family":"Bakhru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dardan","family":"Osmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Kronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Mootoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"92201_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.hoc.2016.05.006","volume":"30","author":"J Ansell","year":"2016","unstructured":"Ansell, J. Reversal agents for the direct oral anticoagulants. Hematol. Oncol. Clinics NA. 30, 1085\u20131098 (2016).","journal-title":"Hematol. Oncol. Clinics NA."},{"key":"92201_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.blre.2016.08.006","volume":"1","author":"BT Samuelson","year":"2017","unstructured":"Samuelson, B. T. & Cuker, A. Measurement and reversal of the direct oral anticoagulants. Blood Rev. 1, 77\u201384 (2017).","journal-title":"Blood Rev."},{"key":"92201_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-0038-1676317","volume":"45","author":"J Ansell","year":"2019","unstructured":"Ansell, J. et al. A novel whole blood point-of-care coagulometer to measure the effect of direct oral anticoagulants and heparins. Semin. Thromb. Hemost. 45, 259\u2013263 (2019).","journal-title":"Semin. Thromb. Hemost."},{"key":"92201_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000441-191304000-00004","volume":"145","author":"RI Lee","year":"1913","unstructured":"Lee, R. I. & White, P. D. A clinical study of the coagulation time of blood. Am. J. Med. Sci. 145, 496\u2013503 (1913).","journal-title":"Am. J. Med. Sci."},{"issue":"9","key":"92201_CR5","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1161\/STROKEAHA.117.017981","volume":"48","author":"M Ebner","year":"2017","unstructured":"Ebner, M. et al. Emergency coagulation assessment during treatment with direct oral anticoagulants: limitations and solutions. Stroke. 48(9), 2457\u20132463 (2017).","journal-title":"Stroke."},{"key":"92201_CR6","doi-asserted-by":"publisher","first-page":"991675","DOI":"10.3389\/fcvm.2022.991675","volume":"9","author":"SD Sahli","year":"2022","unstructured":"Sahli, S. D. et al. The impact of direct oral anticoagulants on viscoelastic testing \u2013 A systematic review. Front. Cardiovasc. Med. 9, 991675 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"92201_CR7","unstructured":"Design Considerations for Pivotal Clinical Investigations for Medical Devices, CDRH\/CBER, FDA, 2013"},{"key":"92201_CR8","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, as in JAMA, 2013 27;310(20):2191\u20134","DOI":"10.1001\/jama.2013.281053"},{"key":"92201_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/2396987317699144","volume":"2","author":"N Ahmed","year":"2017","unstructured":"Ahmed, N., Steiner, T., Caso, V. & Wahlgren, N. Recommendations from the ESO-karolinska stroke update conference, Stockholm 13\u201315 November 2016. Eur. Stroke J. 2, 95\u2013102 (2017).","journal-title":"Eur. Stroke J."},{"key":"92201_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jth.13227","volume":"14","author":"JH Levy","year":"2016","unstructured":"Levy, J. H. et al. Subcommittee on control of anticoagulation. when and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J. Thromb. Haemost.. 14, 623\u2013627 (2016).","journal-title":"J. Thromb. Haemost.."},{"key":"92201_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016659671","author":"L Drouet","year":"2016","unstructured":"Drouet, L. & Sollier, B. D. Measuring nonvitamin K antagonist oral anticoagulant levels: when is it appropriate and which methods should be used?. Int. J. Stroke https:\/\/doi.org\/10.1177\/1747493016659671 (2016).","journal-title":"Int. J. Stroke"},{"key":"92201_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines9050445","volume":"9","author":"D Dunois","year":"2021","unstructured":"Dunois, D. Laboratory monitoring of direct oral anticoagulants (DOACS). Biomedicines 9, 445. https:\/\/doi.org\/10.3390\/biomedicines9050445 (2021).","journal-title":"Biomedicines"},{"key":"92201_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/clinchem\/39.3.405","volume":"39","author":"MH Kroll","year":"1993","unstructured":"Kroll, M. H. & Emancipator, K. A theoretical evaluation of linearity. Clin. Chem. 39, 405\u2013413 (1993).","journal-title":"Clin. Chem."},{"key":"92201_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ehjcvp\/pvw032","volume":"3","author":"T Salmonson","year":"2017","unstructured":"Salmonson, T., Dogne, J. M., Janssen, H., Burgos, J. G. & Blake, P. Non vitamin K oral anticoagulants and laboratory testing: now and in the future. Euro. Heart. J. Cardiovas. Pharmacoth. 3, 42\u201347 (2017).","journal-title":"Euro. Heart. J. Cardiovas. Pharmacoth."},{"key":"92201_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0038-1627480","volume":"118","author":"RC Gosselin","year":"2018","unstructured":"Gosselin, R. C. et al. International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost. 118, 437\u2013450 (2018).","journal-title":"Thromb Haemost."},{"key":"92201_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chest.2017.09.047","volume":"153","author":"A Jabet","year":"2018","unstructured":"Jabet, A. et al. Are screening tests reliable to rule out direct oral anticoagulant plasma levels at various thresholds (30, 50 or 100 ng\/ml) in emergency situations?. Chest. 153, 288\u2013290 (2018).","journal-title":"Chest."},{"key":"92201_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jth.13912","volume":"16","author":"J Douxfils","year":"2018","unstructured":"Douxfils, J. et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J. Thromb. Haemost. 16, 209\u2013219 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"92201_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.thromres.2024.04.005","volume":"237","author":"N Gendron","year":"2024","unstructured":"Gendron, N. et al. Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?. Thromb. Res. 237, 171\u2013180 (2024).","journal-title":"Thromb. Res."},{"key":"92201_CR19","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/jth.13486","volume":"14","author":"S Testa","year":"2016","unstructured":"Testa, S. et al. Poor comparability of coagulation screening tests with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter\/multiplatform study. J. Thromb. Haemost. 14, 2194\u20132201 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"92201_CR20","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1111\/jth.15901","volume":"20","author":"JR Shaw","year":"2022","unstructured":"Shaw, J. R. et al. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J. Thromb. Haemost. 20, 2953\u20132963 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"92201_CR21","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","volume":"2","author":"DM Witt","year":"2018","unstructured":"Witt, D. M. et al. ASH 2018 Guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2, 3257\u20133291 (2018).","journal-title":"Blood Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92201-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:25:31Z","timestamp":1744881931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92201-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92201"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92201-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4850160\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"SHB, XJ, LC, DO, KK, and DM are employees of Perosphere Technologies and have equity interest in the company; SZ has an equity interest in Perosphere Technologies; JA is an advisor to Perosphere Technologies and has equity interest in the company; is an advisor to Alere Home Monitoring, Norgine Pharmaceuticals and Covis Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"7355"}}